Top Markets
Coin of the day
Shanghai Kaibao Pharmaceutical CO.,Ltd Shanghai Kaibao Pharmaceutical CO.,Ltd

Shanghai Kaibao Pharmaceutical CO.,Ltd

300039
Rang in Aktien #10244
Shanghai Kaibao Pharmaceutical CO.,Ltd specializes in the research,... Shanghai Kaibao Pharmaceutical CO.,Ltd specializes in the research, development, manufacturing, and sale of modern Traditional Chinese Medicines, primarily operating within China. Its diverse product lineup features several key pharmaceutical solutions. These include: Tanreqing injection, which is extensively utilized for addressing conditions like pneumonia, acute and chronic bronchitis, and upper respiratory tract infections. Tanreqing capsules, formulated to reduce internal heat, detoxify the system, and clear phlegm. Tiopronin for injection, designed to enhance liver function for various acute and chronic hepatitis patients. Tiopronin enteric-coated tablets, prescribed as a supplementary therapy for managing chronic hepatitis. Xiongdan dropping pills, known for their efficacy in alleviating heat, calming the liver, and promoting improved vision. Established in 2000, the company's operations are based in Shanghai, China.
Aktienkurs
$0.82890742
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$867.04M
Veränderung (1 Tag)
-4.19%
Veränderung (1 Jahr)
-5.58%
Land
CN
Handel Shanghai Kaibao Pharmaceutical CO.,Ltd (300039)

Kategorie

Kursverlauf für Shanghai Kaibao Pharmaceutical CO.,Ltd (300039)
Höchster Schlusskurs: $0.84 am 2026-08-01

Niedrigster Schlusskurs: $0.63 am 2010-01-01
Kursverlauf der Aktie von Shanghai Kaibao Pharmaceutical CO.,Ltd von 2010 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -4.16%
2025 -3.40%
2024 -6.20%
2023 -27.09%
2022 68.71%
2021 3.77%
2020 15.98%
2019 5.35%
2018 -34.16%
2017 -18.68%
2016 -30.43%
2015 26.59%
2014 13.89%
2013 34.59%
2012 -1.86%
2011 -30.49%
2010 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$166.36 31.46%
DE
$37.84 25.87%
JP
$222.33 27.49%
CH
$21.19 17.16%
IN